Jump Financial’s SELLAS Life Sciences SLS Stock Holding History

Jump Financial’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14,627	Closed	-$134K	–	1681
2021 Q3	$134K	Buy	+14,627	New	+$136K	0.01%	942

Other funds holding SLS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Equitable Holdings New York $16.7B AUM 24.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jump Financial's SLS Position: Q4 2021 in Review

Jump Financial sold out of SELLAS Life Sciences (SLS) in Q4 2021, closing a stake of 14,627 shares — an estimated $134K sold.

Jump Financial first reported a position in SLS in Q3 2021 and held it in 1 quarter. The position peaked at $134K in Q3 2021. 27 funds tracked by Wall St. Rank hold SLS as of Q4 2021.

Jump Financial reported no remaining SELLAS Life Sciences position as of Q4 2021 after selling out during the quarter.
Jump Financial sold 14,627 SELLAS Life Sciences shares in Q4 2021, an estimated $134K.
Jump Financial first reported a position in SELLAS Life Sciences in Q3 2021 and held it in 1 quarter.
Jump Financial's SELLAS Life Sciences position peaked at $134K in Q3 2021.
27 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q4 2021.

Based on Jump Financial's 13F filing for Q4 2021, filed 10 Feb 2022.